All-cause deaths 24% higher among vaccinated during Pfizer clinical trials, negative effectiveness reported against new variants, and boosters linked to decreased immunity.
All-cause deaths 24% higher among vaccinated during Pfizer clinical trials, negative effectiveness reported against new variants, and boosters linked to decreased immunity.